Scarica l'app Stockscreener
2.88
25.76%
0.59
Precedente Chiudi:
$2.29
Aprire:
$2.34
Volume 24 ore:
7.39M
Relative Volume:
43.09
Capitalizzazione di mercato:
$6.30M
Reddito:
-
Utile/perdita netta:
$-10.91M
Rapporto P/E:
-0.0362
EPS:
-79.5513
Flusso di cassa netto:
$-12.14M
1 W Prestazione:
+50.00%
1M Prestazione:
+81.13%
6M Prestazione:
+20.00%
1 anno Prestazione:
-93.14%
Intervallo 1D:
$2.33
$3.36
Intervallo di 1 settimana:
$1.84
$3.36
Portata 52W:
$1.36
$80.36
Gri Bio Inc Stock (GRI) Company Profile
Nome
Gri Bio Inc
Settore
Industria
Telefono
(619) 400-1171
Indirizzo
2223 AVENIDA DE LA PLAYA, LA JOLLA
Compare GRI vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
2.88 | 3.65M | 0 | -10.91M | -12.14M | -79.55 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | H.C. Wainwright | Buy |
Gri Bio Inc Borsa (GRI) Ultime notizie
GRI Bio Inc. (GRI) Climbs 3.6% to $1.73 as Buyers Defend Key SupportWyckoff Accumulation - vinanet.vn
GRI Bio Inc. Q1 2026 Earnings: Wider-than-Expected Loss of $1.61 Per Share, Yet Stock Closes Up 3.59 - vinanet.vn
GRI Q1 2026 Earnings: EPS Falls Sharply Short of Estimates as Shares Slide 5.65%Earnings Forecast Report - vinanet.vn
GRI Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
GRI Bio, Inc. 2Q 2026: Net income $(1.64)M, EPS $(0.91) — 10-Q Summary - TradingView
Form 10-Q GRI Bio, Inc. For: Jun 30 - StreetInsider
GRI Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GRI Bio (GRI) investors disclose 4.99% stake capped by warrant blockers - Stock Titan
GRI Q2'26 Earnings: revenue estimate is 0 USD - TradingView
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
GRI Bio Inc expected to post a loss of $1.19 a shareEarnings Preview - TradingView
GRI Bio (GRI) Jumps 15.65% to $1.70 — Breakout Above $1.78 Could Extend RallyFast Moving Stocks - vinanet.vn
GRI Bio Inc (GRI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GRI Bio Inc. (NASDAQ: GRI) Share Price, GRI Stock News, GRI Share Price & Updates - kalkine.com.au
GRI Q1 2026 Earnings: Wider-than-Expected Loss Highlights Clinical-Stage BurnBuyback Announcement Report - vinanet.vn
GRI Bio Inc (GRI) Cash Flow - TradingKey
GRI Bio Inc (GRI) Valuation: PE, PB & Fair Value Analysis - TradingKey
GRI Bio Inc (GRI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GRI Bio Inc (GRI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GRI|GRI Bio Inc|Price:1.420|Chg%:-0.030 - TradingKey
GRI Bio Inc (GRI) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
GRI Bio Inc (GRI) Income Statement - TradingKey
Gri Bio, Inc. (GRI) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
TradingKey - TradingKey
GRI Bio Inc (GRI) Institutional Confidence - TradingKey
GRI Bio, Inc. Revenue Breakdown – NASDAQ:GRI - TradingView
GRI Bio Inc (GRI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to sales forward of GRI Bio, Inc. – NASDAQ:GRI - TradingView
CHGA Stock Price and Chart — NASDAQ:CHGA - TradingView
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
GRI Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin as Pre‑Revenue Biotech Faces Increased CostsReturn On Capital - Vinanet
GRI Bio Inc. (GRI) Retreats 3.23% as Shares Test Support Near $1.42Price Surge Stocks - dars.gov.et
GRI Q1 2026 Earnings: Wider-than-Expected Loss on No RevenueEarnings Analysis - vinanet.vn
GRI Q1 2026 Earnings: EPS Misses Estimates by 76%, No Revenue ReportedReturn On Capital - vinanet.vn
GRI Bio Inc. (GRI) Q1 2026 Earnings: Significant EPS Miss Amid Pre-Revenue StageMargin Guidance - dars.gov.et
GRI Bio Inc. Q1 2026 Earnings: EPS Misses Estimates by 76%, Stock Rises 2.6% Amid Strategic Progress - Bölüm Sonu Canavarı
GRI Bio Inc. (GRI) Q1 2026 Earnings: Wider-than-Expected Loss Exceeds Estimates on Pre-Revenue StatusTech Earnings Analysis - dars.gov.et
Price to earnings forward of GRI Bio, Inc. – NASDAQ:GRI - TradingView
GRI Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue AbsentSubscription Growth Report - dars.gov.et
GRI Bio Inc. (GRI) Declines Over 8%, Approaching Critical Support at $1.73Liquidity Order Flow - dars.gov.et
GRI Q1 2026 Earnings: EPS Misses Estimates by 76%, Shares Slide 8%Mid-Term Outlook - dars.gov.et
Price to sales forward of GRI Bio, Inc. – BOATS:GRI - TradingView
Enterprise value to revenue forward of GRI Bio, Inc. – NASDAQ:GRI - TradingView
GRI Bio Inc. Q1 2026 Earnings: EPS Misses Estimates by over 76% as Pre-Revenue Biotech Continues DevelopmentInterim Report - dars.gov.et
Enterprise value to EBIT forward of GRI Bio, Inc. – NASDAQ:GRI - TradingView
Price to earnings forward of GRI Bio, Inc. – BOATS:GRI - TradingView
Enterprise value to EBIT forward of GRI Bio, Inc. – BOATS:GRI - TradingView
Enterprise value to EBITDA forward of GRI Bio, Inc. – NASDAQ:GRI - TradingView
GRI Q1 2026 Earnings: EPS Miss Widens Losses as Pre-Revenue Biotech Stock RalliesProfit Margin Analysis - DonanımHaber
ADTX Stock Price and Chart — OTC:ADTX - TradingView
GRI Bio, Inc. Actuals & Estimates (NASDAQ:GRI) - TradingView
Gri Bio Inc Azioni (GRI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):